PL2190418T3 - Sposób dawkowania ibuprofenu o natychmiastowym i długotrwałym uwalnianiu - Google Patents

Sposób dawkowania ibuprofenu o natychmiastowym i długotrwałym uwalnianiu

Info

Publication number
PL2190418T3
PL2190418T3 PL07840963T PL07840963T PL2190418T3 PL 2190418 T3 PL2190418 T3 PL 2190418T3 PL 07840963 T PL07840963 T PL 07840963T PL 07840963 T PL07840963 T PL 07840963T PL 2190418 T3 PL2190418 T3 PL 2190418T3
Authority
PL
Poland
Prior art keywords
dosing regimen
release
sustained release
immediate release
immediate
Prior art date
Application number
PL07840963T
Other languages
English (en)
Inventor
Der-Yang Lee
Frank Bunick
James Schwing
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Publication of PL2190418T3 publication Critical patent/PL2190418T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2873—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL07840963T 2007-08-15 2007-08-15 Sposób dawkowania ibuprofenu o natychmiastowym i długotrwałym uwalnianiu PL2190418T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/839,168 US8137694B2 (en) 2007-08-15 2007-08-15 Immediate release and sustained release ibuprofen dosing regimen
EP07840963.8A EP2190418B1 (en) 2007-08-15 2007-08-15 Immediate release and sustained release ibuprofen dosing regimen
PCT/US2007/075990 WO2009023030A1 (en) 2007-08-15 2007-08-15 Immediate release and sustained release ibuprofen dosing regiment

Publications (1)

Publication Number Publication Date
PL2190418T3 true PL2190418T3 (pl) 2014-03-31

Family

ID=59676846

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07840963T PL2190418T3 (pl) 2007-08-15 2007-08-15 Sposób dawkowania ibuprofenu o natychmiastowym i długotrwałym uwalnianiu

Country Status (13)

Country Link
US (2) US8137694B2 (pl)
EP (2) EP2630955B1 (pl)
JP (1) JP5345620B2 (pl)
KR (1) KR101458774B1 (pl)
CN (1) CN101784262A (pl)
AU (4) AU2007357647A1 (pl)
BR (1) BRPI0721969A2 (pl)
CA (1) CA2696063C (pl)
ES (1) ES2438267T3 (pl)
HK (1) HK1144071A1 (pl)
MX (1) MX2010001789A (pl)
PL (1) PL2190418T3 (pl)
WO (1) WO2009023030A1 (pl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2010001789A (es) * 2007-08-15 2010-03-10 Mcneil Ppc Inc Regimen de dosificacion de ibuprofeno de liberacion inmediata y liberacion sostenida.
KR20140014350A (ko) * 2009-03-12 2014-02-06 큠버랜드 파마슈티컬즈 인코포레이티드 정맥 내 투여용 이부프로펜의 투여
US8871810B2 (en) * 2009-07-15 2014-10-28 Cumberland Pharmaceuticals Inc. Treating critically ill patients with intravenous ibuprofen
US8735452B2 (en) * 2009-07-15 2014-05-27 Cumberland Pharmaceuticals Inc. Treating patients with intravenous ibuprofen
WO2011014208A1 (en) * 2009-07-31 2011-02-03 Leo Pavliv Treating critically ill patients with intravenous ibuprofen
CN102160855B (zh) * 2011-03-30 2013-01-23 吴家安 右旋布洛芬缓释片及制备方法
CN102813638A (zh) * 2011-06-07 2012-12-12 贵阳医学院 一种右旋酮洛芬氨丁三醇双层缓释片的制备方法
JP2015503583A (ja) * 2012-01-04 2015-02-02 ウェルズリー ファーマスーティカルズ、エルエルシー 排尿頻度を減少させるための延長放出製剤およびその使用の方法
CA2864858A1 (en) * 2012-02-20 2013-08-29 Lupin Limited Bilayer tablet of dronedarone
US9072661B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
US9072710B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
US20140037725A1 (en) * 2012-08-01 2014-02-06 Cadila Healthcare Limited Bilayer pharmaceutical compositions of naproxen
ES2919874T3 (es) * 2014-09-24 2022-07-28 Vital Beverages Global Inc Composiciones y métodos para el suministro selectivo en el tubo gastrointestinal
ES2954452T3 (es) * 2015-10-09 2023-11-22 Bayer Healthcare Llc Formulación de liberación modificada de naproxeno sódico
CN113995755A (zh) 2016-02-04 2022-02-01 辛多美制药有限公司 氘代多潘立酮组合物和用于治疗病症的方法
EA201992116A1 (ru) 2017-03-08 2020-01-29 СИНРКС ФАРМА, ЭлЭлСи Фармацевтические составы флороглюцинола и триметилфлороглюцинола
KR20240125702A (ko) 2017-06-30 2024-08-19 신돔 파마, 인크. 중수소화 돔페리돈 조성물, 방법, 및 제조
TR201721036A2 (tr) * 2017-12-21 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Flurbi̇profeni̇n modi̇fi̇ye salimli formülasyonlari
CN110037994B (zh) * 2019-05-24 2022-04-12 中国药科大学 一种布洛芬速释缓释双层片及其制备方法
CN113842371A (zh) * 2021-10-11 2021-12-28 江苏集萃新型药物制剂技术研究所有限公司 一种双相释药组合物、双相释药固体药剂及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1497044A (en) * 1974-03-07 1978-01-05 Prodotti Antibiotici Spa Salts of phenyl-alkanoic acids
US4873231A (en) 1986-04-08 1989-10-10 Smith Walton J Decreasing the toxicity of an ibuprofen salt
IT1200178B (it) 1986-07-23 1989-01-05 Alfa Farmaceutici Spa Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
CA2061520C (en) * 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency
IT1264855B1 (it) * 1993-06-21 1996-10-17 Zambon Spa Composizioni farmaceutiche contenenti sali dell'acido s(+)-2-(4-isobutilfenil) propionico con amminoacidi basici
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
US6183778B1 (en) * 1993-09-21 2001-02-06 Jagotec Ag Pharmaceutical tablet capable of liberating one or more drugs at different release rates
IT1276689B1 (it) 1995-06-09 1997-11-03 Applied Pharma Res Forma farmaceutica solida ad uso orale
JP3950175B2 (ja) * 1997-05-30 2007-07-25 オスモティカ・コーポレイション 多層浸透デバイス
US6753009B2 (en) * 2002-03-13 2004-06-22 Mcneil-Ppc, Inc. Soft tablet containing high molecular weight polyethylene oxide
MXPA05010010A (es) 2003-03-21 2006-03-10 Johnson & Johnson Regimen de dosificacion de farmaco anti-inflamatorio no-esteroideo.
US20040186180A1 (en) 2003-03-21 2004-09-23 Gelotte Cathy K. Non-steroidal anti-inflammatory drug dosing regimen
MX2010001789A (es) * 2007-08-15 2010-03-10 Mcneil Ppc Inc Regimen de dosificacion de ibuprofeno de liberacion inmediata y liberacion sostenida.

Also Published As

Publication number Publication date
WO2009023030A8 (en) 2010-11-25
HK1144071A1 (en) 2011-01-28
EP2190418A1 (en) 2010-06-02
EP2630955B1 (en) 2021-09-22
CN101784262A (zh) 2010-07-21
AU2016203727A1 (en) 2016-06-23
KR101458774B1 (ko) 2014-11-07
MX2010001789A (es) 2010-03-10
CA2696063A1 (en) 2009-02-19
BRPI0721969A2 (pt) 2015-09-29
WO2009023030A1 (en) 2009-02-19
AU2014203508A1 (en) 2014-07-17
US8211465B2 (en) 2012-07-03
ES2438267T3 (es) 2014-01-16
EP2190418B1 (en) 2013-10-02
AU2007357647A1 (en) 2009-02-19
KR20100045509A (ko) 2010-05-03
CA2696063C (en) 2014-05-06
AU2018201651A1 (en) 2018-03-29
EP2630955A1 (en) 2013-08-28
US8137694B2 (en) 2012-03-20
US20090048345A1 (en) 2009-02-19
US20120136060A1 (en) 2012-05-31
JP5345620B2 (ja) 2013-11-20
AU2018201651B2 (en) 2019-01-03
JP2010536748A (ja) 2010-12-02

Similar Documents

Publication Publication Date Title
HK1144071A1 (en) Immediate release and sustained release ibuprofen dosing regimen
ZA200904436B (en) Modified release ibuprofen solid oral dosage form
HK1107002A1 (en) Modified release ibuprofen dosage form
EP2089910A4 (en) NANO-PHOTOVOLTAIC ARRANGEMENT WITH IMPROVED QUANTITY EFFICIENCY
IL211802A0 (en) Nmda receptor modulators and uses thereof
PL2367519T3 (pl) Urządzenie dawkujące i dozujące
EP2318366A4 (en) PSMA-BONDING SUBSTANCES AND ITS USE
EP2315816A4 (en) CUTTING MATERIALS
IL204528A (en) Pharmaceutical dosage forms for immediate sustained release of metadoxin
GB2454890B (en) Light-emitting device and materials therefor
IL234296B (en) dosage regimen
EP2090300A4 (en) PREPARATION WITH EXTENDED RELEASE
EP2197448A4 (en) dosing schedule
EP2336263A4 (en) HEAT-RESISTANT AND EXTREMELY THERMAL SOLVENT
GB2459257B (en) Particulate dispenser
ZA201104710B (en) Pharmaceutical dispenser and use thereof
AU315923S (en) Triangular spoutless pouch
ZA201208210B (en) A combination composition comprising ibuprofen and paracetamal
HK1187256A1 (en) Anti-hypertensive agent
EP2067480A4 (en) MUSCLIN RECEPTOR AND USE THEREOF
EP2273266A4 (en) PARASPORIN-1 RECEPTOR AND USE THEREOF
EP2307022A4 (en) ENHANCED NON-STEROID ANTI-INFLAMMATORY FORMULATIONS (NSAIDs)
GB2454144B (en) Dosing device
PL1970496T3 (pl) Układ dozujący
ZA200702694B (en) Modified release ibuprofen dosage form